Ping An Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Cap	19	25	-	-	-	-
Enterprise Value	21.56	21.74	0	0	0	0
Last Close Price	0.16	1.24	-	-	-	-
PS Ratio	4.22	5.30	-	-	-	-
PB Ratio	0.52	4.00	-	-	-	-
P/TBV Ratio	0.06	0.51	-	-	-	-
EV/Sales Ratio	4.49	4.53	-	-	-	-
Debt / Equity Ratio	0.22	0.22	-1.46	-7.26	7.72	-13.85
Debt / EBITDA Ratio	-	-	1318.51	66.58	3.28	3.49
Debt / FCF Ratio	-	-	0.74	-	1.69	-
Net Debt / Equity Ratio	-0.58	-0.58	-1.49	-7.23	7.48	-13.99
Net Debt / EBITDA Ratio	1.79	1.79	1302.55	65.66	3.17	3.48
Net Debt / FCF Ratio	4.08	4.08	0.73	-6.96	1.63	-0.92
Asset Turnover	0.58	0.55	1.28	1.02	1.47	1.89
Inventory Turnover	115.63	116.65	49.58	20.04	9.73	7.80
Quick Ratio	2.74	2.74	0.84	0.86	0.96	0.72
Current Ratio	2.76	2.76	0.84	0.89	1.02	0.93
Return on Equity (ROE)	-76.60%	-67.43%	19.68%	157.76%	569.72%	-236.42%
Return on Assets (ROA)	-21.95%	-20.51%	-0.01%	-18.05%	10.43%	10.46%
Return on Invested Capital (ROIC)	-33.42%	-34.96%	-0.01%	-20.90%	12.25%	10.45%
Return on Capital Employed (ROCE)	-86.78%	-76.15%	0.03%	-102.65%	830.75%	-425.35%
Payout Ratio	-	0.00%	-25.11%	-966.23%	66.84%	0.00%
Buyback Yield / Dilution	-2.66%	-2.66%	0.00%	0.00%	0.00%	0.00%
Total Shareholder Return	-2.66%	-2.66%	0.00%	0.00%	0.00%	0.00%